FTSE All-Share
5.617,32
PKT
-162,93
PKT
-2,82
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.07.12 | BP hold | Société Générale Group S.A. (SG) | |
| 23.07.12 | BP outperform | RBC Capital Markets | |
| 23.07.12 | Vodafone Group overweight | J.P. Morgan Cazenove | |
| 23.07.12 | Unilever hold | Société Générale Group S.A. (SG) | |
| 23.07.12 | EVRAZ overweight | Morgan Stanley | |
| 23.07.12 | Vodafone Group overweight | Morgan Stanley | |
| 23.07.12 | Anglo American halten | Independent Research GmbH | |
| 23.07.12 | Anglo American sector perform | RBC Capital Markets | |
| 20.07.12 | Vodafone Group sell | Société Générale Group S.A. (SG) | |
| 20.07.12 | Anglo American buy | Sarasin Research | |
| 20.07.12 | Kingfisher outperform | Exane-BNP Paribas SA | |
| 20.07.12 | Kingfisher neutral | Citigroup Corp. | |
| 20.07.12 | Kingfisher hold | Société Générale Group S.A. (SG) | |
| 20.07.12 | 3i equal-weight | Morgan Stanley | |
| 20.07.12 | Vodafone Group buy | ING | |
| 20.07.12 | Vodafone Group kaufen | National-Bank AG | |
| 19.07.12 | Vodafone Group buy | Banc of America Securities-Merrill Lynch | |
| 19.07.12 | Rio Tinto overweight | HSBC | |
| 19.07.12 | Anglo American overweight | HSBC | |
| 19.07.12 | Pearson buy | UBS AG | |
| 19.07.12 | Kingfisher buy | Sarasin Research | |
| 19.07.12 | Next buy | UBS AG | |
| 19.07.12 | BT Group buy | Banc of America Securities-Merrill Lynch | |
| 19.07.12 | GSK outperform | Exane-BNP Paribas SA | |
| 19.07.12 | Shell (ex Royal Dutch Shell) sector perform | RBC Capital Markets | |
| 19.07.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 19.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 19.07.12 | BP overweight | J.P. Morgan Cazenove | |
| 18.07.12 | Sky buy | Deutsche Bank AG | |
| 18.07.12 | Shell (ex Royal Dutch Shell) sector perform | RBC Capital Markets | |
| 18.07.12 | Kingfisher buy | Deutsche Bank AG | |
| 18.07.12 | Rio Tinto outperform | RBC Capital Markets | |
| 18.07.12 | GSK buy | Banc of America Securities-Merrill Lynch | |
| 18.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 18.07.12 | GSK neutral | Credit Suisse Group | |
| 18.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 18.07.12 | Rio Tinto buy | UBS AG | |
| 18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | Weir Group reduce | Nomura | |
| 18.07.12 | GSK neutral | Nomura |